Eisai 483 Handed Form 483 after Investigators Cite Control Records, CAPA Procedures
The FDA has served drug manufacturer Eisai Inc. with a Form 483 after an investigation revealed laboratory control issues and incomplete records.
Source: Drug Industry Daily